Key points from article :
NHS patients with lymphoma have for the first time been given a pioneering treatment.
Therapy called CAR-T is a "living drug" that is tailor-made for each patient using their body's own cells.
Therapy genetically reprogrammes their immune system to fight cancer.
T-cells are removed from the patient's blood, then they are frozen in liquid nitrogen, sent to the USA.
In the USA T-cells are genetically reprogrammed for seeking out and destroying cancer.
Millions of the modified cells are grown in the lab, then being shipped back to the UK.
Modified CAR-T cells are injected back into the patient.
Whole manufacturing process takes a month.